Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid for reducing bleeding during external dacryocystorhinostomy
IRCT20260820070735N1Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tranexamic acid in dacryostenosis, sponsored by Mashhad University of Medical Sciences. Primary endpoints: Intraoperative bleeding volume and Duration of surgery. Started Sep 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
dacryostenosis
Beyond the preview
Go deeper on IRCT20260820070735N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260820070735N1.